Table 2.
Demographic and clinical parameters of study patients.
| Clinical Parameters | Group 1 | Group 2 | p Value |
|---|---|---|---|
| Age, years | 57.09 ± 7.99 | 67.98 ± 10.32 | *** p < 0.0001 |
| Gender: male female |
22 (51.2%) 21 (48.8%) |
20 (46.5%) 23 (53.5%) |
p > 0.050 |
| Weight, kg | 79.64 ± 15.00 | 84.87 ± 15.88 | p > 0.050 |
| BMI, kg/m2 | 28.56 ± 4.72 | 30.95 ± 5.21 | * p = 0.030 |
| Systolic BP, mmHg | 136.70 ± 21.06 | 148.35 ± 22.69 | * p = 0.039 |
| Diastolic BP, mmHg | 82.44 ± 10.03 | 83.72 ± 16.63 | p > 0.050 |
| HbA1c, % | 7.34 ± 1.53 | 7.83 ± 1.83 | p > 0.050 |
| Fasting Plasma Glucose, mg/dl | 135.28 ± 49.21 | 142.65 ± 60.31 | p > 0.050 |
| Insulin, µU/ml | 10.94 ± 10.76 | 13.33 ± 9.97 | p > 0.050 |
| HOMA-IR | 3.48 ± 2.99 | 4.41 ± 3.20 | p > 0.050 |
| Triglycerides, mg/dl | 182.40 ± 256.01 | 177.05 ± 79.64 | * p = 0.011 |
| Total cholesterol, mg/dl | 184.21 ± 36.16 | 171.63 ± 44.61 | p > 0.050 |
| HDL cholesterol, mg/dl | 48.44 ± 14.93 | 45.30 ± 13.34 | p > 0.050 |
| LDL cholesterol, mg/dl | 115.88 ± 36.62 | 100.12 ± 36.63 | p > 0.050 |
| UKPDS CHD 10-year risk score |
14.79 ± 9.48 | 27.89 ± 17.52 | *** p < 0.0001 |
| UKPDS FATAL CHD 10-year risk score |
9.62 ± 7.39 | 22.51 ± 16.49 | *** p < 0.0001 |
| UKPDS STROKE 10-year risk score |
7.27 ± 6.29 | 21.84 ± 16.27 | *** p < 0.0001 |
| UKPDS FATAL STROKE 10-year risk score |
1.14 ± 1.09 | 3.84 ± 3.34 | *** p < 0.0001 |
* p < 0.05; *** p < 0.001 Group 2 vs. Group 1.